Actively Recruiting
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Led by Duke University · Updated on 2025-11-19
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are creating a blood sample repository from adults diagnosed with primary or metastatic brain tumors treated at the Duke Cancer Center Radiation Oncology Department. This observational study aims to explore how circulating biomarkers relate to outcomes following radiation therapy in these patients. Participants provide blood samples that will be studied to understand the association between circulating immune cells and treatment effects. The research focuses on collecting samples at specific times, including six weeks after radiation therapy, to measure immune cell levels. During the study, participants undergo blood draws for sample collection, and researchers monitor the number of circulating immune cells in the blood six weeks post-treatment. The study involves no active intervention, and participation duration varies depending on treatment schedules and sample collection timing. The main outcome is the number of circulating immune cells after radiation therapy.
CONDITIONS
Brief Title
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 weeks post radiation therapy
Participants provide blood samples to study circulating biomarkers related to radiation therapy outcomes.
1 to 2 visits depending on timing of radiation therapy
Trial Site Locations
Total: 1 location
1
Duke Cancer Center
Durham, North Carolina, United States, 27710
Actively Recruiting
Research Team
K
Kaitlin Bailey, RN OCN
L
Linda Kaltenbach, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here